PDL BioPharma, Inc. Retained Earnings
PDL BioPharma, Inc. had Retained Earnings of $485.49 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-03-29
- 2020-06-30: Retained Earnings (Accumulated Deficit) $485.49M.
- 2020-03-31: Retained Earnings (Accumulated Deficit) $621.13M.
- 2019-12-31: Retained Earnings (Accumulated Deficit) $670.83M.
- 2019-09-30: Retained Earnings (Accumulated Deficit) $736.70M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2020-06-30 | $485.49M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $621.13M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $670.83M 10-K · filed 2021-03-29 |
| 2019-09-30 | $736.70M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $759.08M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $790.40M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $828.55M 8-K · filed 2020-06-29 |
| 2018-09-30 | $835.57M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $811.40M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $944.25M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $945.61M 10-K · filed 2019-03-15 |
| 2017-09-30 | $923.38M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $932.52M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $872.08M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $857.12M 10-K · filed 2018-03-16 |
| 2016-09-30 | $867.44M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $853.54M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $857.67M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $810.04M 10-K · filed 2017-03-01 |
| 2015-09-30 | $709.47M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $640.02M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $561.78M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $575.74M 10-K · filed 2016-02-23 |
| 2014-09-30 | $520.98M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $418.75M 10-Q · filed 2014-08-18 |
| 2014-03-31 | $326.81M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $350.15M 10-K · filed 2015-02-23 |
| 2013-09-30 | $289.06M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $232.83M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $139.12M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $169.63M 10-K · filed 2014-03-03 |
| 2012-09-30 | $120.23M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $71.65M 10-Q · filed 2012-08-02 |
| 2012-03-31 | -$1.85M 10-Q · filed 2012-05-03 |
| 2011-12-31 | -$42.03M 10-K · filed 2013-03-01 |
| 2011-09-30 | -$80.98M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$126.89M 10-Q · filed 2011-07-29 |
| 2011-03-31 | -$196.88M 10-Q · filed 2011-04-28 |
| 2010-12-31 | -$241.42M 10-K · filed 2012-02-23 |
| 2010-09-30 | -$216.96M 10-Q · filed 2010-11-09 |
| 2010-06-30 | -$257.15M 10-Q · filed 2010-07-29 |
| 2009-12-31 | -$333.30M 10-K · filed 2011-03-01 |